tirzepatide microdosing protocol I'm starting a new longevity protocol: Tirzepatide, a dual GLP-1/GIP receptor agonist. Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention. 🧵 Microdose tirzepatide schedule: the complete

Semaglutide (Wegovy) a licensed GLP-1 receptor agonist approved by the MHRA for weight management in eligible adults, as assessed in NICE technology appraisal TA875

Some users report pseudoglycemia, a condition characterized by dizziness, weakness, slight limb tremor, and hunger that occurs even when blood glucose is technically normal

Clinics in Dermatology

We offer prior authorization support for semaglutide in Maple Valley, conducting diligent follow-ups until approval

Patients who adjust their eating behavior and incorporate appropriate physical activity tend to achieve better and more sustainable results

They were residents of Bangkok and recruited through the dermatology clinic at King Chulalongkorn Memorial Hospital